- GE Healthcare
- Koninklijke Philips N.V.
- Siemens Healthineers
- Canon Corporation
- Shimadzu Corporation
- Boston Scientific Corporation
- Cordis Corporation
- Medtronic, Inc.
- AngioDynamics
- B. Braun Melsungen
- Abbott Laboratories
(Note: The list of the major players will be updated with the latest market scenario and trends)
Recent Developments in Angiography Equipment Market:
-
In April 2023- GE Healthcare, the Veluson TM EXPERT 22, which offers several benefits in angiography procedures, including reduced radiation exposure, enhanced visualization, and others, won the "Best New Ultrasound Technology Solution" price in the 7th annual MedTech Breakthrough Awards Medical device category. The MedTech Breakthrough Awards recognize the institutions, businesses, and services advancing medical and digital health advances in a crowded market.
The increasing prevalence of technological advancements, including advanced image quality, 3D imaging capabilities, and real-time monitoring integration, has significantly boosted the potential of the angiography equipment market during the forecast period. This evolution empowers healthcare professionals with heightened precision in diagnostics, enabling them to accurately determine intricate vascular details and abnormalities. The convergence of these advanced features fosters superior patient outcomes by facilitating early detection of conditions, precise treatment planning, and minimally invasive interventions, thus catalyzing the demand for angiography equipment in the Healthcare sector. Moreover, the collaborative and interprofessional synergy within the healthcare team, which is crucial for the successful execution of angiography procedures, is anticipated to propel the market expansion. This effort provides seamless coordination between various specialists, such as cardiologists, radiologists, nurses, and technologists, optimizing the accuracy and efficacy of angiography. Such a holistic approach enhances patient care by enabling comprehensive evaluation, precise diagnoses, and well-informed treatment decisions, consequently fostering the demand for angiography equipment market. Furthermore, the risk of radiation exposure during angiography procedures significantly restricts the market growth. While angiography plays a crucial role in diagnosing and guiding interventions, the potential health risks associated with ionizing radiation exposure have raised valid concerns among patients and healthcare practitioners. This concern over radiation-related health hazards could deter certain patients from opting for angiography procedures, thereby impacting the adoption rate of these interventions and potentially hindering the expansion of the angiography equipment market.